Ana María Vega-Letter

Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies

Daniela N. Urrutia, Pablo Caviedes, Rodrigo Mardones et al. · PLoS ONE · 2019 · 126 citations · Full text

Adult Stem Cell, Biomedical Engineering, Regenerative Medicine +18

The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential

Rafael Contreras‐López, Roberto Elizondo‐Vega, Noymar Luque‐Campos et al. · Theranostics · 2020 · 65 citations · Full text

HIF1α‐dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions

Rafael Contreras‐López, Roberto Elizondo‐Vega, M.J. Paredes et al. · The FASEB Journal · 2020 · 64 citations · Full text

Th17 Cell Generation, Nitric Oxide, T-regulatory Cell +24

Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE

Mónica Kurte, Ana María Vega-Letter, Patricia Luz‐Crawford et al. · Stem Cell Research & Therapy · 2020 · 64 citations · Full text

Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium–induced colitis model

Patricia Fuenzalida, Mónica Kurte, Catalina Fernández-O’Ryan et al. · Cytotherapy · 2016 · 49 citations

Inflammation, Anti-inflammatory, Mucosal Immunology +11